|
维持性血液透析患者发生心力衰竭的风险预测模型构建
|
Abstract:
目的:构建维持性血液透析(maintenance hemodialysis, MHD)患者发生心力衰竭(heart failure, HF)的风险预测模型,分析MHD患者发生心力衰竭(HF)的因素,以早期识别并减少不良的预后。方法:回顾性收集2021~2023年青海大学附属医院住院MHD患者的资料,以MHD患者是否发生HF为结局事件分为HF组(n = 59)和非HF组(n = 297),比较两组研究对象的基线特征,按照7:3的比例将MHD患者随机分为建模集(n = 250)和验证集(n = 106)。通过LASSO回归确定预测变量,通过二分类逻辑回归建立MHD患者发生HF的风险预测模型并开发列线图;采用受试者工作特征(ROC)曲线下面积评估模型的区分度。结果:建模集42例(16.8%)MHD患者发生HF,验证集17例(16.04%)患者发生HF。LASSO回归结合Logistic回归分析结果显示,高血压(OR = 4.05, 95% CI = 1.86~9.30)、C反应蛋白异常(OR = 3.04, 95% CI = 1.45~6.71)、透析频次3次/周(OR = 4.08, 95% CI = 1.80~9.97)、透析龄(OR = 1.18, 95% CI = 1.02~1.36)是MHD患者发生SF的独立影响因素(P<0.05)。构建包含上述4个影响因素的风险预测模型并绘制列线图。该预测模型在建模集和验证集的ROC曲线下面积分别为0.785 (95% CI = 0.7124~0.8575)和0.746 (95% CI = 0.6103~0.8821),区分度良好。结论:高血压、C反应蛋白异常、透析频次3次/周、透析龄是MHD患者发生HF的独立危险因素;预测模型的区分度良好。
Objective: To construct a risk prediction model for heart failure (HF) in patients on maintenance hemodialysis (MHD) and to explore the risk factors for heart failure (HF) in MHD patients so as to identify and reduce adverse prognosis at an early stage. Methods: Data of MHD patients hospitalized in the Affiliated Hospital of Qinghai University from 2021 to 2023 were collected. These patients were divided into the HF group (n = 59) and the non-HF group (n = 297) based on whether they developed HF as the outcome event. The baseline characteristics of the two groups were compared, and the patients were randomly divided into a modeling set (n = 250) and a validation set (n = 106) in a ratio of 7:3. The predictor variables were determined by LASSO regression, and a prediction model for HF in MHD patients was constructed by binary logistic regression and a nomogram was drawn. The area under the receiver operating characteristic (ROC) curve was used to evaluate the discrimination of the model. Results: HF occurred in 42 (16.8%) MHD patients in the modeling set and 17 (16.04%) patients in the validation set. LASSO regression combined with Logistic regression analysis showed that hypertension (OR = 4.05, 95% CI = 1.86~9.30), abnormal C-reactive protein (OR = 3.04, 95% CI = 1.45~6.71), dialysis frequency 3 times/week (OR = 4.08, 95% CI = 1.80~9.97), and dialysis age (OR = 1.18, 95% CI = 1.02~1.36) were independent influencing factors for SF in MHD patients (P < 0.05). A risk prediction model including the above four influencing factors was constructed and a nomogram was drawn. The areas under the ROC curve of the prediction model in the modeling set and validation set were 0.785 (95% CI = 0.7124~0.8575) and
[1] | Greenberg, K.I. and Choi, M.J. (2021) Hemodialysis Emergencies: Core Curriculum 2021. American Journal of Kidney Diseases, 77, 796-809. https://doi.org/10.1053/j.ajkd.2020.11.024 |
[2] | Wang, F., Yang, C., Long, J., Zhao, X., Tang, W., Zhang, D., et al. (2019) Executive Summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET). Kidney International, 95, 501-505. https://doi.org/10.1016/j.kint.2018.11.011 |
[3] | Lai, A.C., Bienstock, S.W., Sharma, R., Skorecki, K., Beerkens, F., Samtani, R., et al. (2021) A Personalized Approach to Chronic Kidney Disease and Cardiovascular Disease JACC Review Topic of the Week. Journal of the American College of Cardiology, 77, 1470-1479. https://doi.org/10.1016/j.jacc.2021.01.028 |
[4] | Chen, N., Pan, X., Gu, Y., Mao, P., Ni, Z., Ding, X., et al. (2012) Analysis of Early Kidney Damage in Hospitalized Patients with Chronic Kidney Disease: A Multicenter Study. Renal Failure, 34, 329-333. https://doi.org/10.3109/0886022x.2011.647303 |
[5] | 刘卫华, 林紫宁, 洪富源. 血液透析并发心力衰竭的防治新进展[J]. 中国实用内科杂志, 2021, 41(11): 917-921. |
[6] | 李立. 维持性血液透析患者微炎症状态与血管通路功能丧失的相关性研究[D]: [硕士学位论文]. 南京: 东南大学, 2006. |
[7] | 李熙惠. 通过体外细胞培养观察血液透析对内皮细胞功能的变化及其可能机制[D]: [硕士学位论文]. 南宁: 广西医科大学, 2019. |
[8] | 张倩. 西宁地区hif-phi治疗维持性血液透析患者肾性贫血的疗效观察[D]: [硕士学位论文]. 西宁: 青海大学, 2022. |
[9] | 郑淑蓓, 陈琰, 潘敏, 等. 血清可溶性klotho蛋白与维持性血液透析患者心血管疾病及预后的关系[J]. 中华肾脏病杂志, 2017, 33(4): 264-270. |
[10] | 唐文武, 袁心柱, 杨小华, 等. 维持性血液透析患者心力衰竭住院预测模型的开发和外部验证[J]. 中国血液净化, 2023, 22(12): 909-915. |
[11] | 罗承志, 陈剑泉. 维持性血液透析患者血清肌钙蛋白t和b型钠尿肽水平的变化及意义[J]. 山西医药杂志, 2017, 46(5): 587-590. |
[12] | 王仲甜, 宋娜. 维持性血液透析患者心脑血管疾病的风险预测模型的建立[J]. 中国医药科学, 2024, 14(19): 176-179, 198. |
[13] | 刘真秀, 董铭, 林立文, 等. 《中国老年高血压管理指南2019》解读[J]. 长春中医药大学学报, 2020, 36(5): 1076-1079. |
[14] | 邓梦玲. 维持性血液透析患者残余肾功能对心衰发生的影响[D]: [硕士学位论文]. 芜湖: 皖南医学院, 2023. |
[15] | 许丽苹. 机器学习算法建立腹膜透析患者心衰及全因死亡预测模型的研究[D]: [硕士学位论文]. 福州: 福建医科大学, 2021. |
[16] | 李金聪. 沙库巴曲缬沙坦对不同类型lvef心衰的维持性血液透析患者疗效评估[D]: [硕士学位论文]. 十堰: 湖北医药学院, 2024. |
[17] | 李萍. 基于imb模型的健康教育对维持性血液透析患者健康素养影响的研究[D]: [硕士学位论文]. 青岛: 青岛大学, 2023. |